In the News: NeoMend
February 1, 2010 Leave a comment
Last week, socaltech.com reported that NeoMend, Inc. of Irvine, CA has raised $30M in a Series D funding round. According to their website, NeoMend markets a patented hydrogel technology for use in wound sealing, prevention of post-surgical adhesions, and site-specific sustained drug delivery. NeoMend’s patents include U.S. Patent No. 7,351,249, issued on April 1, 2008.
The ’249 patent describes a biocompatible material which can be used to seal a puncture site in a blood vessel and to seal a suture knot. According to the USPTO database, NeoMend is listed as the assignee for fourteen U.S. patents, including the one featured here. Earlier this month, NeoMend also received pre-market approval from the FDA for its ProGEL™ Pleural Air Leak Sealant, for use in lung surgery.
Follow me on Twitter
